{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:34:44Z","timestamp":1788345284333,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd010189","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,4,20]],"date-time":"2014-04-20T00:00:00Z","timestamp":1397952000000}}],"reference-count":84,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010189.pub2","type":"journal-article","created":{"date-parts":[[2014,4,20]],"date-time":"2014-04-20T05:36:43Z","timestamp":1397972203000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults"],"prefix":"10.1002","volume":"2014","author":[{"given":"Udo","family":"Holtick","sequence":"first","affiliation":[{"name":"University Hospital of Cologne; Department I of Internal Medicine, Stem Cell Transplantation Program; Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Albrecht","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Department I of Internal Medicine, Stem Cell Transplantation Program; Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens M","family":"Chemnitz","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Department I of Internal Medicine, Stem Cell Transplantation Program; Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Theurich","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Department I of Internal Medicine, Stem Cell Transplantation Program; Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Skoetz","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Scheid","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Department I of Internal Medicine, Stem Cell Transplantation Program; Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"von Bergwelt-Baildon","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Department I of Internal Medicine, Stem Cell Transplantation Program; Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,4,20]]},"reference":[{"issue":"16","key":"10.1002\/14651858.CD010189.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"The New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010189.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2002-01-0048","article-title":"A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies","volume":"100","author":"Couban","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(09)70352-3","article-title":"Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial","volume":"11","author":"Friedrichs","year":"2010","journal-title":"Lancet Oncology"},{"issue":"5","key":"10.1002\/14651858.CD010189.pub2-BIB0004|cit4","first-page":"643","article-title":"Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial","volume":"90","author":"Schmitz","year":"2005","journal-title":"Haematologica"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2001-12-0304","article-title":"Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia","volume":"100","author":"Schmitz","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub2-BIB0006|cit6","first-page":"86","article-title":"Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease","volume":"90","author":"Abrahamson","year":"2005","journal-title":"Haematologica"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sj.bmt.1704127","article-title":"Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study","volume":"32","author":"Heldal","year":"2003","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bmt.1701906","article-title":"Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Mahmoud","year":"1999","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers","volume":"344","author":"Bensinger","year":"2001","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010189.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","article-title":"Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial","volume":"100","author":"Flowers","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1182\/blood-2011-12-396275","article-title":"Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear versus bone marrow","volume":"119","author":"Mielcarek","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD010189.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbmt.2004.09.010","article-title":"Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia","volume":"11","author":"Oehler","year":"2005","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","article-title":"Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle","volume":"18","author":"Blaise","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD010189.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1182\/blood.V100.9.3128","article-title":"Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study","volume":"100","author":"Mohty","year":"2002","journal-title":"Blood"},{"issue":"9211","key":"10.1002\/14651858.CD010189.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","article-title":"Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial","volume":"355","author":"Powles","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0016|cit16","first-page":"1281","article-title":"Quality of life in patients randomized to receive a bone marrow or a peripheral blood allograft","volume":"87","author":"Souza","year":"2002","journal-title":"Haematologica"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1399-3062.2003.00033.x","article-title":"Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation","volume":"5","author":"Nucci","year":"2003","journal-title":"Transplant Infectious Disease"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.bmt.1701510","article-title":"A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies","volume":"22","author":"Vigorito","year":"1998","journal-title":"Bone Marrow Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD010189.pub2-BIB0019|cit19","first-page":"665","article-title":"A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: an update","volume":"86","author":"Vigorito","year":"2001","journal-title":"Haematologica"},{"issue":"8","key":"10.1002\/14651858.CD010189.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3324\/haematol.2011.054841","article-title":"Bone marrow\u00a0versus\u00a0peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups","volume":"97","author":"Bacigalupo","year":"2012","journal-title":"Haematologica"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub2-BIB0021|cit21","first-page":"3702","article-title":"Blood\u00a0stem cells\u00a0compared\u00a0with bone marrow as a source of hematopoietic\u00a0cells\u00a0for allogeneic transplantation. IBMTR Histocompatibility and\u00a0Stem\u00a0Cell Sources Working Committee and the European Group for\u00a0Blood\u00a0and Marrow Transplantation (EBMT)","volume":"95","author":"Champlin\u00a0RE","year":"2000","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD010189.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0301-472X(03)00195-4","article-title":"A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies","volume":"31","author":"Cornelissen\u00a0JJ","year":"2003","journal-title":"Experimental Hematology"},{"issue":"9","key":"10.1002\/14651858.CD010189.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1704245","article-title":"Differences\u00a0between graft product and donor side effects following bone marrow or stem cell donation","volume":"32","author":"Favre\u00a0G","year":"2003","journal-title":"Bone Marrow Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD010189.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood.V104.11.3321.3321","article-title":"Peripheral blood stem cells vs bone marrow for matched sibling transplant in AML and ALL remission [abstract]","volume":"104","author":"Kirschbaum","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1182\/blood.V98.12.3186","article-title":"Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells","volume":"98","author":"Morton\u00a0J","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD010189.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbmt.2009.07.009","article-title":"Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation","volume":"15","author":"Pidala","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1473-0502(03)00104-6","article-title":"Blood\u00a0versus\u00a0marrow hematopoietic allogeneic graft","volume":"29","author":"Robinet\u00a0E","year":"2003","journal-title":"Transfusion and Apheresis Science"},{"issue":"11","key":"10.1002\/14651858.CD010189.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","article-title":"Immune\u00a0reconstitution\u00a0after allogeneic marrow transplantation compared with blood stem cell transplantation","volume":"97","author":"Storek\u00a0J","year":"2001","journal-title":"Blood"},{"issue":"15","key":"10.1002\/14651858.CD010189.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1056\/NEJMp078166","article-title":"Hematopoietic-cell transplantation at 50","volume":"357","author":"Appelbaum","year":"2007","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/bmt.2011.11","article-title":"The EBMT activity survey 2009: trends over the past 5 years","volume":"46","author":"Baldomero","year":"2011","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow\u00a0as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers","volume":"344","author":"Bensinger\u00a0WI","year":"2001","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010189.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CCO.0b013e32834f5c27","article-title":"Allogeneic transplantation: peripheral blood vs. bone marrow","volume":"24","author":"Bensinger","year":"2012","journal-title":"Current Opinion in Oncology"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","article-title":"Randomized\u00a0trial\u00a0of bone marrow versus\u00a0lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle","volume":"18","author":"Blaise\u00a0D","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD010189.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.bbmt.2013.06.008","article-title":"Outcomes of patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies","volume":"19","author":"Brunner","year":"2013","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00277-011-1299-8","article-title":"Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials","volume":"91","author":"Chang","year":"2012","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.2007.06524.x","article-title":"Long-term safety of filgrastim (rhG-CSF) administration","volume":"137","author":"Confer","year":"2007","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0037|cit37","doi-asserted-by":"crossref","unstructured":"Confer DL Miller JP Chell JW Bone marrow and peripheral blood cell donors and donor registries Frederick R. Appelbaum Stephen J. Forman Robert S. Negrin Karl G. Blume Thomas' Hematopietic Cell Transplantation 4th Edition Oxford, UK Wiley-Blackwell 544 58","DOI":"10.1002\/9781444303537.ch38"},{"issue":"2","key":"10.1002\/14651858.CD010189.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1537-2995.2001.41020190.x","article-title":"CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF","volume":"41","author":"de\u00a0Fabritiis","year":"2001","journal-title":"Transfusion"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub2-BIB0039|cit39","first-page":"1281","article-title":"Quality of life in patients randomized to receive a bone marrow or a peripheral blood allograft","volume":"87","author":"Souza","year":"2002","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0040|cit40","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.bbmt.2007.08.006","article-title":"Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival","volume":"13","author":"Eapen","year":"2007","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"9674","key":"10.1002\/14651858.CD010189.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD010189.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.coi.2006.07.014","article-title":"Donor selection for unrelated cord blood transplants","volume":"18","author":"Gluckman","year":"2006","journal-title":"Current Opinion in Immunology"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1586\/ehm.12.65","article-title":"Assessing response of therapy for acute and chronic graft-versus-host disease","volume":"6","author":"Goldberg","year":"2013","journal-title":"Expert Reviews in Hematology"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.bmt.1705555","article-title":"Results of EBMT activity survey 2005 on hematopoietic stem cell transplantation: Focus on increasing use of unrelated donors","volume":"39","author":"Gratwohl","year":"2007","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/bmt.2009.7","article-title":"The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies","volume":"43","author":"Gratwohl","year":"2009","journal-title":"Bone Marrow Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD010189.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3324\/haematol.2012.076349","article-title":"Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study","volume":"98","author":"Gratwohl","year":"2013","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0050|cit50","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0051|cit51","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0052|cit52","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.blre.2005.01.007","article-title":"Chronic graft-versus-host disease","volume":"20","author":"Horwitz","year":"2006","journal-title":"Blood Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrc2804","article-title":"Allogeneic hematopoietic stem cell transplantation: individualized stem cell and immunotherapy of cancer","volume":"10","author":"Jenq","year":"2010","journal-title":"Nature Reviews of Cancer"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0055|cit55","volume-title":"The Statistical Analysis of Failure Time Data","author":"Kalb\ufb02eisch","year":"1980"},{"issue":"4","key":"10.1002\/14651858.CD010189.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/leu.2011.257","article-title":"Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study","volume":"26","author":"Kuzmina","year":"2012","journal-title":"Leukemia"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0057|cit57","unstructured":"Labopin M Iacobelli S Statistical guidelines for EBMT http:\/\/www.ebmt.org\/1WhatisEBMT\/Op_Manual\/OPMAN_StatGuidelines_oct2003.pdf"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0058|cit58","unstructured":"Labopin M Latouche A Suciu S Santucci A Canals C Iacobelli S Definitions and evaluation of endpoints following stem cells transplantation - recommendation from the European group for Blood and Marrow transplantation (EBMT). CLINT, Work Package 5 2009 http:\/\/portal.ebmt.org\/sites\/clint2\/clint\/Documents\/Statistical%20Endpoints_CLINT%20Project_final%20version.pdf"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0059|cit59","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"10","key":"10.1002\/14651858.CD010189.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD010189.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbmt.2012.02.013","article-title":"Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"18","author":"Nagler","year":"2012","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/j.seminhematol.2011.10.004","article-title":"Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation","volume":"49","author":"Norkin","year":"2012","journal-title":"Seminars in Hematology"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bmt.2009.328","article-title":"New perspectives on the biology of acute GVHD","volume":"45","author":"Paczesny","year":"2009","journal-title":"Bone Marrow Transplantation"},{"issue":"24","key":"10.1002\/14651858.CD010189.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0065|cit65","unstructured":"Pasquini MC Wang Z Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2013 Available at: http:\/\/www.cibmtr.org"},{"issue":"25","key":"10.1002\/14651858.CD010189.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1056\/NEJMoa011826","article-title":"Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation","volume":"345","author":"Petersdorf","year":"2001","journal-title":"The New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD010189.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbmt.2009.07.009","article-title":"Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation","volume":"15","author":"Pidala","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2008-10-182592","article-title":"Quality of life after allogeneic hematopoietic cell transplantation","volume":"114","author":"Pidala","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD010189.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/COC.0b013e31817f9de1","article-title":"Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Pollack","year":"2009","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0070|cit70","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"5","key":"10.1002\/14651858.CD010189.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2141.2009.07886.x","article-title":"The allogeneic graft-versus-cancer effect","volume":"147","author":"Ringden","year":"2009","journal-title":"British Journal of Haematology"},{"issue":"5","key":"10.1002\/14651858.CD010189.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2796.2012.02547.x","article-title":"Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients","volume":"272","author":"Ringden","year":"2012","journal-title":"Journal of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010189.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2001-12-0304","article-title":"Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia","volume":"100","author":"Schmitz","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1002\/14651858.CD010189.pub2-BIB0074|cit74","first-page":"643","article-title":"Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial","volume":"90","author":"Schmitz\u00a0N","year":"2005","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0075|cit75","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD010189.pub2-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006406.pub2","article-title":"Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors","author":"Siddiq","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"17","key":"10.1002\/14651858.CD010189.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.2011.1558","article-title":"Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies","volume":"306","author":"Sorror","year":"2011","journal-title":"Journal of the American Medical Association"},{"issue":"22","key":"10.1002\/14651858.CD010189.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1200\/JCO.2005.09.020","article-title":"Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematological malignancies: an individual patient data meta-analysis of nine randomised trials","volume":"23","author":"Stem Cell Trialists' Collaborative Croup","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD010189.pub2-BIB0079|cit79","first-page":"539","article-title":"Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs. bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of the day 11 methotrexate administration","volume":"38","author":"Stem Cell Trialists' Collaborative Group","year":"2006","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0080|cit80","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010189.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"12","key":"10.1002\/14651858.CD010189.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.bmt.1701510","article-title":"A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies","volume":"22","author":"Vigorito\u00a0AC","year":"1998","journal-title":"Bone Marrow Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD010189.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.bbmt.2012.06.014","article-title":"Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning","volume":"18","author":"Weisdorf","year":"2012","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD010189.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/bmt.2013.70","article-title":"Comorbidity burden in patients with chronic GVHD","volume":"48","author":"Wood","year":"2013","journal-title":"Bone Marrow Transplantation"}],"updated-by":[{"DOI":"10.1002\/14651858.cd010189.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010189.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T18:48:29Z","timestamp":1698518909000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010189.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,20]]},"references-count":84,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010189.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD010189.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,20]]}}}